Figure 5From: Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program Cost effectiveness acceptability curve showing the probability that using RI-HSCT is cost-effective compared with BT-ICT. RI-HSCT: Reduced intensity hematopoietic stem cell transplantation; BT-ICT: Blood transfusion combined with iron chelating therapy.Back to article page